Global Psoriasis Biologics Drugs Market Growth 2022-2028
The report requires updating with new data and is sent in 48 hours after order is placed.
The global market for Psoriasis Biologics Drugs is estimated to increase from US$ million in 2021 to reach US$ million by 2028, exhibiting a CAGR of % during 2022-2028. Keeping in mind the uncertainties of COVID-19 and Russia-Ukraine War, we are continuously tracking and evaluating the direct as well as the indirect influence of the pandemic on different end use sectors. These insights are included in the report as a major market contributor.
The APAC Psoriasis Biologics Drugs market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.
The United States Psoriasis Biologics Drugs market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.
The Europe Psoriasis Biologics Drugs market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.
The China Psoriasis Biologics Drugs market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.
Global key Psoriasis Biologics Drugs players cover Amgen, UCB, Johnson & Johnson, Abbive and Innovent, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.
Report Coverage
This latest report provides a deep insight into the global Psoriasis Biologics Drugs market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, value chain analysis, etc.
This report aims to provide a comprehensive picture of the global Psoriasis Biologics Drugs market, with both quantitative and qualitative data, to help readers understand how the Psoriasis Biologics Drugs market scenario changed across the globe during the pandemic and Russia-Ukraine War.
The base year considered for analyses is 2021, while the market estimates and forecasts are given from 2022 to 2028. The market estimates are provided in terms of revenue in USD millions and volume in K Units.
Market Segmentation:
The study segments the Psoriasis Biologics Drugs market and forecasts the market size by Type (TNF-? Inhibitor, IL-12/23 Target Drug and IL-17 Target Drug), by Application (Hospital Pharmacies, Retail Pharmacies and Online Pharmacies,), and region (APAC, Americas, Europe, and Middle East & Africa).
Segmentation by type
Chapter 1: Scope of Psoriasis Biologics Drugs, Research Methodology, etc.
Chapter 2: Executive Summary, global Psoriasis Biologics Drugs market size (sales and revenue) and CAGR, Psoriasis Biologics Drugs market size by region, by type, by application, historical data from 2017 to 2022, and forecast to 2028.
Chapter 3: Psoriasis Biologics Drugs sales, revenue, average price, global market share, and industry ranking by company, 2017-2022
Chapter 4: Global Psoriasis Biologics Drugs sales and revenue by region and by country. Country specific data and market value analysis for the U.S., Canada, Europe, China, Japan, South Korea, Southeast Asia, India, Latin America and Middle East & Africa.
Chapter 5, 6, 7, 8: Americas, APAC, Europe, Middle East & Africa, sales segment by country, by type, and type.
Chapter 9: Analysis of the current market trends, market forecast, opportunities and economic trends that are affecting the future marketplace
Chapter 10: Manufacturing cost structure analysis
Chapter 11: Sales channel, distributors, and customers
Chapter 12: Global Psoriasis Biologics Drugs market size forecast by region, by country, by type, and application.
Chapter 13: Comprehensive company profiles of the leading players, including Amgen, UCB, Johnson & Johnson, Abbive, Innovent, Biocad, Novartis, Eli Lilly and Sun Pharmaceutical, etc.
Chapter 14: Research Findings and Conclusion
The global market for Psoriasis Biologics Drugs is estimated to increase from US$ million in 2021 to reach US$ million by 2028, exhibiting a CAGR of % during 2022-2028. Keeping in mind the uncertainties of COVID-19 and Russia-Ukraine War, we are continuously tracking and evaluating the direct as well as the indirect influence of the pandemic on different end use sectors. These insights are included in the report as a major market contributor.
The APAC Psoriasis Biologics Drugs market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.
The United States Psoriasis Biologics Drugs market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.
The Europe Psoriasis Biologics Drugs market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.
The China Psoriasis Biologics Drugs market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.
Global key Psoriasis Biologics Drugs players cover Amgen, UCB, Johnson & Johnson, Abbive and Innovent, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.
Report Coverage
This latest report provides a deep insight into the global Psoriasis Biologics Drugs market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, value chain analysis, etc.
This report aims to provide a comprehensive picture of the global Psoriasis Biologics Drugs market, with both quantitative and qualitative data, to help readers understand how the Psoriasis Biologics Drugs market scenario changed across the globe during the pandemic and Russia-Ukraine War.
The base year considered for analyses is 2021, while the market estimates and forecasts are given from 2022 to 2028. The market estimates are provided in terms of revenue in USD millions and volume in K Units.
Market Segmentation:
The study segments the Psoriasis Biologics Drugs market and forecasts the market size by Type (TNF-? Inhibitor, IL-12/23 Target Drug and IL-17 Target Drug), by Application (Hospital Pharmacies, Retail Pharmacies and Online Pharmacies,), and region (APAC, Americas, Europe, and Middle East & Africa).
Segmentation by type
- TNF-? Inhibitor
- IL-12/23 Target Drug
- IL-17 Target Drug
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Amgen
- UCB
- Johnson & Johnson
- Abbive
- Innovent
- Biocad
- Novartis
- Eli Lilly
- Sun Pharmaceutical
Chapter 1: Scope of Psoriasis Biologics Drugs, Research Methodology, etc.
Chapter 2: Executive Summary, global Psoriasis Biologics Drugs market size (sales and revenue) and CAGR, Psoriasis Biologics Drugs market size by region, by type, by application, historical data from 2017 to 2022, and forecast to 2028.
Chapter 3: Psoriasis Biologics Drugs sales, revenue, average price, global market share, and industry ranking by company, 2017-2022
Chapter 4: Global Psoriasis Biologics Drugs sales and revenue by region and by country. Country specific data and market value analysis for the U.S., Canada, Europe, China, Japan, South Korea, Southeast Asia, India, Latin America and Middle East & Africa.
Chapter 5, 6, 7, 8: Americas, APAC, Europe, Middle East & Africa, sales segment by country, by type, and type.
Chapter 9: Analysis of the current market trends, market forecast, opportunities and economic trends that are affecting the future marketplace
Chapter 10: Manufacturing cost structure analysis
Chapter 11: Sales channel, distributors, and customers
Chapter 12: Global Psoriasis Biologics Drugs market size forecast by region, by country, by type, and application.
Chapter 13: Comprehensive company profiles of the leading players, including Amgen, UCB, Johnson & Johnson, Abbive, Innovent, Biocad, Novartis, Eli Lilly and Sun Pharmaceutical, etc.
Chapter 14: Research Findings and Conclusion
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Psoriasis Biologics Drugs Annual Sales 2017-2028
2.1.2 World Current & Future Analysis for Psoriasis Biologics Drugs by Geographic Region, 2017, 2022 & 2028
2.1.3 World Current & Future Analysis for Psoriasis Biologics Drugs by Country/Region, 2017, 2022 & 2028
2.2 Psoriasis Biologics Drugs Segment by Type
2.2.1 TNF-? Inhibitor
2.2.2 IL-12/23 Target Drug
2.2.3 IL-17 Target Drug
2.3 Psoriasis Biologics Drugs Sales by Type
2.3.1 Global Psoriasis Biologics Drugs Sales Market Share by Type (2017-2022)
2.3.2 Global Psoriasis Biologics Drugs Revenue and Market Share by Type (2017-2022)
2.3.3 Global Psoriasis Biologics Drugs Sale Price by Type (2017-2022)
2.4 Psoriasis Biologics Drugs Segment by Application
2.4.1 Hospital Pharmacies
2.4.2 Retail Pharmacies
2.4.3 Online Pharmacies
2.5 Psoriasis Biologics Drugs Sales by Application
2.5.1 Global Psoriasis Biologics Drugs Sale Market Share by Application (2017-2022)
2.5.2 Global Psoriasis Biologics Drugs Revenue and Market Share by Application (2017-2022)
2.5.3 Global Psoriasis Biologics Drugs Sale Price by Application (2017-2022)
3 GLOBAL PSORIASIS BIOLOGICS DRUGS BY COMPANY
3.1 Global Psoriasis Biologics Drugs Breakdown Data by Company
3.1.1 Global Psoriasis Biologics Drugs Annual Sales by Company (2020-2022)
3.1.2 Global Psoriasis Biologics Drugs Sales Market Share by Company (2020-2022)
3.2 Global Psoriasis Biologics Drugs Annual Revenue by Company (2020-2022)
3.2.1 Global Psoriasis Biologics Drugs Revenue by Company (2020-2022)
3.2.2 Global Psoriasis Biologics Drugs Revenue Market Share by Company (2020-2022)
3.3 Global Psoriasis Biologics Drugs Sale Price by Company
3.4 Key Manufacturers Psoriasis Biologics Drugs Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Psoriasis Biologics Drugs Product Location Distribution
3.4.2 Players Psoriasis Biologics Drugs Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 WORLD HISTORIC REVIEW FOR PSORIASIS BIOLOGICS DRUGS BY GEOGRAPHIC REGION
4.1 World Historic Psoriasis Biologics Drugs Market Size by Geographic Region (2017-2022)
4.1.1 Global Psoriasis Biologics Drugs Annual Sales by Geographic Region (2017-2022)
4.1.2 Global Psoriasis Biologics Drugs Annual Revenue by Geographic Region
4.2 World Historic Psoriasis Biologics Drugs Market Size by Country/Region (2017-2022)
4.2.1 Global Psoriasis Biologics Drugs Annual Sales by Country/Region (2017-2022)
4.2.2 Global Psoriasis Biologics Drugs Annual Revenue by Country/Region
4.3 Americas Psoriasis Biologics Drugs Sales Growth
4.4 APAC Psoriasis Biologics Drugs Sales Growth
4.5 Europe Psoriasis Biologics Drugs Sales Growth
4.6 Middle East & Africa Psoriasis Biologics Drugs Sales Growth
5 AMERICAS
5.1 Americas Psoriasis Biologics Drugs Sales by Country
5.1.1 Americas Psoriasis Biologics Drugs Sales by Country (2017-2022)
5.1.2 Americas Psoriasis Biologics Drugs Revenue by Country (2017-2022)
5.2 Americas Psoriasis Biologics Drugs Sales by Type
5.3 Americas Psoriasis Biologics Drugs Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Psoriasis Biologics Drugs Sales by Region
6.1.1 APAC Psoriasis Biologics Drugs Sales by Region (2017-2022)
6.1.2 APAC Psoriasis Biologics Drugs Revenue by Region (2017-2022)
6.2 APAC Psoriasis Biologics Drugs Sales by Type
6.3 APAC Psoriasis Biologics Drugs Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Psoriasis Biologics Drugs by Country
7.1.1 Europe Psoriasis Biologics Drugs Sales by Country (2017-2022)
7.1.2 Europe Psoriasis Biologics Drugs Revenue by Country (2017-2022)
7.2 Europe Psoriasis Biologics Drugs Sales by Type
7.3 Europe Psoriasis Biologics Drugs Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Psoriasis Biologics Drugs by Country
8.1.1 Middle East & Africa Psoriasis Biologics Drugs Sales by Country (2017-2022)
8.1.2 Middle East & Africa Psoriasis Biologics Drugs Revenue by Country (2017-2022)
8.2 Middle East & Africa Psoriasis Biologics Drugs Sales by Type
8.3 Middle East & Africa Psoriasis Biologics Drugs Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Psoriasis Biologics Drugs
10.3 Manufacturing Process Analysis of Psoriasis Biologics Drugs
10.4 Industry Chain Structure of Psoriasis Biologics Drugs
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Psoriasis Biologics Drugs Distributors
11.3 Psoriasis Biologics Drugs Customer
12 WORLD FORECAST REVIEW FOR PSORIASIS BIOLOGICS DRUGS BY GEOGRAPHIC REGION
12.1 Global Psoriasis Biologics Drugs Market Size Forecast by Region
12.1.1 Global Psoriasis Biologics Drugs Forecast by Region (2023-2028)
12.1.2 Global Psoriasis Biologics Drugs Annual Revenue Forecast by Region (2023-2028)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Psoriasis Biologics Drugs Forecast by Type
12.7 Global Psoriasis Biologics Drugs Forecast by Application
13 KEY PLAYERS ANALYSIS
13.1 Amgen
13.1.1 Amgen Company Information
13.1.2 Amgen Psoriasis Biologics Drugs Product Offered
13.1.3 Amgen Psoriasis Biologics Drugs Sales, Revenue, Price and Gross Margin (2020-2022)
13.1.4 Amgen Main Business Overview
13.1.5 Amgen Latest Developments
13.2 UCB
13.2.1 UCB Company Information
13.2.2 UCB Psoriasis Biologics Drugs Product Offered
13.2.3 UCB Psoriasis Biologics Drugs Sales, Revenue, Price and Gross Margin (2020-2022)
13.2.4 UCB Main Business Overview
13.2.5 UCB Latest Developments
13.3 Johnson & Johnson
13.3.1 Johnson & Johnson Company Information
13.3.2 Johnson & Johnson Psoriasis Biologics Drugs Product Offered
13.3.3 Johnson & Johnson Psoriasis Biologics Drugs Sales, Revenue, Price and Gross Margin (2020-2022)
13.3.4 Johnson & Johnson Main Business Overview
13.3.5 Johnson & Johnson Latest Developments
13.4 Abbive
13.4.1 Abbive Company Information
13.4.2 Abbive Psoriasis Biologics Drugs Product Offered
13.4.3 Abbive Psoriasis Biologics Drugs Sales, Revenue, Price and Gross Margin (2020-2022)
13.4.4 Abbive Main Business Overview
13.4.5 Abbive Latest Developments
13.5 Innovent
13.5.1 Innovent Company Information
13.5.2 Innovent Psoriasis Biologics Drugs Product Offered
13.5.3 Innovent Psoriasis Biologics Drugs Sales, Revenue, Price and Gross Margin (2020-2022)
13.5.4 Innovent Main Business Overview
13.5.5 Innovent Latest Developments
13.6 Biocad
13.6.1 Biocad Company Information
13.6.2 Biocad Psoriasis Biologics Drugs Product Offered
13.6.3 Biocad Psoriasis Biologics Drugs Sales, Revenue, Price and Gross Margin (2020-2022)
13.6.4 Biocad Main Business Overview
13.6.5 Biocad Latest Developments
13.7 Novartis
13.7.1 Novartis Company Information
13.7.2 Novartis Psoriasis Biologics Drugs Product Offered
13.7.3 Novartis Psoriasis Biologics Drugs Sales, Revenue, Price and Gross Margin (2020-2022)
13.7.4 Novartis Main Business Overview
13.7.5 Novartis Latest Developments
13.8 Eli Lilly
13.8.1 Eli Lilly Company Information
13.8.2 Eli Lilly Psoriasis Biologics Drugs Product Offered
13.8.3 Eli Lilly Psoriasis Biologics Drugs Sales, Revenue, Price and Gross Margin (2020-2022)
13.8.4 Eli Lilly Main Business Overview
13.8.5 Eli Lilly Latest Developments
13.9 Sun Pharmaceutical
13.9.1 Sun Pharmaceutical Company Information
13.9.2 Sun Pharmaceutical Psoriasis Biologics Drugs Product Offered
13.9.3 Sun Pharmaceutical Psoriasis Biologics Drugs Sales, Revenue, Price and Gross Margin (2020-2022)
13.9.4 Sun Pharmaceutical Main Business Overview
13.9.5 Sun Pharmaceutical Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Psoriasis Biologics Drugs Annual Sales 2017-2028
2.1.2 World Current & Future Analysis for Psoriasis Biologics Drugs by Geographic Region, 2017, 2022 & 2028
2.1.3 World Current & Future Analysis for Psoriasis Biologics Drugs by Country/Region, 2017, 2022 & 2028
2.2 Psoriasis Biologics Drugs Segment by Type
2.2.1 TNF-? Inhibitor
2.2.2 IL-12/23 Target Drug
2.2.3 IL-17 Target Drug
2.3 Psoriasis Biologics Drugs Sales by Type
2.3.1 Global Psoriasis Biologics Drugs Sales Market Share by Type (2017-2022)
2.3.2 Global Psoriasis Biologics Drugs Revenue and Market Share by Type (2017-2022)
2.3.3 Global Psoriasis Biologics Drugs Sale Price by Type (2017-2022)
2.4 Psoriasis Biologics Drugs Segment by Application
2.4.1 Hospital Pharmacies
2.4.2 Retail Pharmacies
2.4.3 Online Pharmacies
2.5 Psoriasis Biologics Drugs Sales by Application
2.5.1 Global Psoriasis Biologics Drugs Sale Market Share by Application (2017-2022)
2.5.2 Global Psoriasis Biologics Drugs Revenue and Market Share by Application (2017-2022)
2.5.3 Global Psoriasis Biologics Drugs Sale Price by Application (2017-2022)
3 GLOBAL PSORIASIS BIOLOGICS DRUGS BY COMPANY
3.1 Global Psoriasis Biologics Drugs Breakdown Data by Company
3.1.1 Global Psoriasis Biologics Drugs Annual Sales by Company (2020-2022)
3.1.2 Global Psoriasis Biologics Drugs Sales Market Share by Company (2020-2022)
3.2 Global Psoriasis Biologics Drugs Annual Revenue by Company (2020-2022)
3.2.1 Global Psoriasis Biologics Drugs Revenue by Company (2020-2022)
3.2.2 Global Psoriasis Biologics Drugs Revenue Market Share by Company (2020-2022)
3.3 Global Psoriasis Biologics Drugs Sale Price by Company
3.4 Key Manufacturers Psoriasis Biologics Drugs Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Psoriasis Biologics Drugs Product Location Distribution
3.4.2 Players Psoriasis Biologics Drugs Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 WORLD HISTORIC REVIEW FOR PSORIASIS BIOLOGICS DRUGS BY GEOGRAPHIC REGION
4.1 World Historic Psoriasis Biologics Drugs Market Size by Geographic Region (2017-2022)
4.1.1 Global Psoriasis Biologics Drugs Annual Sales by Geographic Region (2017-2022)
4.1.2 Global Psoriasis Biologics Drugs Annual Revenue by Geographic Region
4.2 World Historic Psoriasis Biologics Drugs Market Size by Country/Region (2017-2022)
4.2.1 Global Psoriasis Biologics Drugs Annual Sales by Country/Region (2017-2022)
4.2.2 Global Psoriasis Biologics Drugs Annual Revenue by Country/Region
4.3 Americas Psoriasis Biologics Drugs Sales Growth
4.4 APAC Psoriasis Biologics Drugs Sales Growth
4.5 Europe Psoriasis Biologics Drugs Sales Growth
4.6 Middle East & Africa Psoriasis Biologics Drugs Sales Growth
5 AMERICAS
5.1 Americas Psoriasis Biologics Drugs Sales by Country
5.1.1 Americas Psoriasis Biologics Drugs Sales by Country (2017-2022)
5.1.2 Americas Psoriasis Biologics Drugs Revenue by Country (2017-2022)
5.2 Americas Psoriasis Biologics Drugs Sales by Type
5.3 Americas Psoriasis Biologics Drugs Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Psoriasis Biologics Drugs Sales by Region
6.1.1 APAC Psoriasis Biologics Drugs Sales by Region (2017-2022)
6.1.2 APAC Psoriasis Biologics Drugs Revenue by Region (2017-2022)
6.2 APAC Psoriasis Biologics Drugs Sales by Type
6.3 APAC Psoriasis Biologics Drugs Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Psoriasis Biologics Drugs by Country
7.1.1 Europe Psoriasis Biologics Drugs Sales by Country (2017-2022)
7.1.2 Europe Psoriasis Biologics Drugs Revenue by Country (2017-2022)
7.2 Europe Psoriasis Biologics Drugs Sales by Type
7.3 Europe Psoriasis Biologics Drugs Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Psoriasis Biologics Drugs by Country
8.1.1 Middle East & Africa Psoriasis Biologics Drugs Sales by Country (2017-2022)
8.1.2 Middle East & Africa Psoriasis Biologics Drugs Revenue by Country (2017-2022)
8.2 Middle East & Africa Psoriasis Biologics Drugs Sales by Type
8.3 Middle East & Africa Psoriasis Biologics Drugs Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Psoriasis Biologics Drugs
10.3 Manufacturing Process Analysis of Psoriasis Biologics Drugs
10.4 Industry Chain Structure of Psoriasis Biologics Drugs
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Psoriasis Biologics Drugs Distributors
11.3 Psoriasis Biologics Drugs Customer
12 WORLD FORECAST REVIEW FOR PSORIASIS BIOLOGICS DRUGS BY GEOGRAPHIC REGION
12.1 Global Psoriasis Biologics Drugs Market Size Forecast by Region
12.1.1 Global Psoriasis Biologics Drugs Forecast by Region (2023-2028)
12.1.2 Global Psoriasis Biologics Drugs Annual Revenue Forecast by Region (2023-2028)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Psoriasis Biologics Drugs Forecast by Type
12.7 Global Psoriasis Biologics Drugs Forecast by Application
13 KEY PLAYERS ANALYSIS
13.1 Amgen
13.1.1 Amgen Company Information
13.1.2 Amgen Psoriasis Biologics Drugs Product Offered
13.1.3 Amgen Psoriasis Biologics Drugs Sales, Revenue, Price and Gross Margin (2020-2022)
13.1.4 Amgen Main Business Overview
13.1.5 Amgen Latest Developments
13.2 UCB
13.2.1 UCB Company Information
13.2.2 UCB Psoriasis Biologics Drugs Product Offered
13.2.3 UCB Psoriasis Biologics Drugs Sales, Revenue, Price and Gross Margin (2020-2022)
13.2.4 UCB Main Business Overview
13.2.5 UCB Latest Developments
13.3 Johnson & Johnson
13.3.1 Johnson & Johnson Company Information
13.3.2 Johnson & Johnson Psoriasis Biologics Drugs Product Offered
13.3.3 Johnson & Johnson Psoriasis Biologics Drugs Sales, Revenue, Price and Gross Margin (2020-2022)
13.3.4 Johnson & Johnson Main Business Overview
13.3.5 Johnson & Johnson Latest Developments
13.4 Abbive
13.4.1 Abbive Company Information
13.4.2 Abbive Psoriasis Biologics Drugs Product Offered
13.4.3 Abbive Psoriasis Biologics Drugs Sales, Revenue, Price and Gross Margin (2020-2022)
13.4.4 Abbive Main Business Overview
13.4.5 Abbive Latest Developments
13.5 Innovent
13.5.1 Innovent Company Information
13.5.2 Innovent Psoriasis Biologics Drugs Product Offered
13.5.3 Innovent Psoriasis Biologics Drugs Sales, Revenue, Price and Gross Margin (2020-2022)
13.5.4 Innovent Main Business Overview
13.5.5 Innovent Latest Developments
13.6 Biocad
13.6.1 Biocad Company Information
13.6.2 Biocad Psoriasis Biologics Drugs Product Offered
13.6.3 Biocad Psoriasis Biologics Drugs Sales, Revenue, Price and Gross Margin (2020-2022)
13.6.4 Biocad Main Business Overview
13.6.5 Biocad Latest Developments
13.7 Novartis
13.7.1 Novartis Company Information
13.7.2 Novartis Psoriasis Biologics Drugs Product Offered
13.7.3 Novartis Psoriasis Biologics Drugs Sales, Revenue, Price and Gross Margin (2020-2022)
13.7.4 Novartis Main Business Overview
13.7.5 Novartis Latest Developments
13.8 Eli Lilly
13.8.1 Eli Lilly Company Information
13.8.2 Eli Lilly Psoriasis Biologics Drugs Product Offered
13.8.3 Eli Lilly Psoriasis Biologics Drugs Sales, Revenue, Price and Gross Margin (2020-2022)
13.8.4 Eli Lilly Main Business Overview
13.8.5 Eli Lilly Latest Developments
13.9 Sun Pharmaceutical
13.9.1 Sun Pharmaceutical Company Information
13.9.2 Sun Pharmaceutical Psoriasis Biologics Drugs Product Offered
13.9.3 Sun Pharmaceutical Psoriasis Biologics Drugs Sales, Revenue, Price and Gross Margin (2020-2022)
13.9.4 Sun Pharmaceutical Main Business Overview
13.9.5 Sun Pharmaceutical Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Psoriasis Biologics Drugs Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)
Table 2. Psoriasis Biologics Drugs Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)
Table 3. Major Players of TNF-? Inhibitor
Table 4. Major Players of IL-12/23 Target Drug
Table 5. Major Players of IL-17 Target Drug
Table 6. Global Psoriasis Biologics Drugs Sales by Type (2017-2022) & (K Units)
Table 7. Global Psoriasis Biologics Drugs Sales Market Share by Type (2017-2022)
Table 8. Global Psoriasis Biologics Drugs Revenue by Type (2017-2022) & ($ million)
Table 9. Global Psoriasis Biologics Drugs Revenue Market Share by Type (2017-2022)
Table 10. Global Psoriasis Biologics Drugs Sale Price by Type (2017-2022) & (US$/Unit)
Table 11. Global Psoriasis Biologics Drugs Sales by Application (2017-2022) & (K Units)
Table 12. Global Psoriasis Biologics Drugs Sales Market Share by Application (2017-2022)
Table 13. Global Psoriasis Biologics Drugs Revenue by Application (2017-2022)
Table 14. Global Psoriasis Biologics Drugs Revenue Market Share by Application (2017-2022)
Table 15. Global Psoriasis Biologics Drugs Sale Price by Application (2017-2022) & (US$/Unit)
Table 16. Global Psoriasis Biologics Drugs Sales by Company (2020-2022) & (K Units)
Table 17. Global Psoriasis Biologics Drugs Sales Market Share by Company (2020-2022)
Table 18. Global Psoriasis Biologics Drugs Revenue by Company (2020-2022) ($ Millions)
Table 19. Global Psoriasis Biologics Drugs Revenue Market Share by Company (2020-2022)
Table 20. Global Psoriasis Biologics Drugs Sale Price by Company (2020-2022) & (US$/Unit)
Table 21. Key Manufacturers Psoriasis Biologics Drugs Producing Area Distribution and Sales Area
Table 22. Players Psoriasis Biologics Drugs Products Offered
Table 23. Psoriasis Biologics Drugs Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
Table 24. New Products and Potential Entrants
Table 25. Mergers & Acquisitions, Expansion
Table 26. Global Psoriasis Biologics Drugs Sales by Geographic Region (2017-2022) & (K Units)
Table 27. Global Psoriasis Biologics Drugs Sales Market Share Geographic Region (2017-2022)
Table 28. Global Psoriasis Biologics Drugs Revenue by Geographic Region (2017-2022) & ($ millions)
Table 29. Global Psoriasis Biologics Drugs Revenue Market Share by Geographic Region (2017-2022)
Table 30. Global Psoriasis Biologics Drugs Sales by Country/Region (2017-2022) & (K Units)
Table 31. Global Psoriasis Biologics Drugs Sales Market Share by Country/Region (2017-2022)
Table 32. Global Psoriasis Biologics Drugs Revenue by Country/Region (2017-2022) & ($ millions)
Table 33. Global Psoriasis Biologics Drugs Revenue Market Share by Country/Region (2017-2022)
Table 34. Americas Psoriasis Biologics Drugs Sales by Country (2017-2022) & (K Units)
Table 35. Americas Psoriasis Biologics Drugs Sales Market Share by Country (2017-2022)
Table 36. Americas Psoriasis Biologics Drugs Revenue by Country (2017-2022) & ($ Millions)
Table 37. Americas Psoriasis Biologics Drugs Revenue Market Share by Country (2017-2022)
Table 38. Americas Psoriasis Biologics Drugs Sales by Type (2017-2022) & (K Units)
Table 39. Americas Psoriasis Biologics Drugs Sales Market Share by Type (2017-2022)
Table 40. Americas Psoriasis Biologics Drugs Sales by Application (2017-2022) & (K Units)
Table 41. Americas Psoriasis Biologics Drugs Sales Market Share by Application (2017-2022)
Table 42. APAC Psoriasis Biologics Drugs Sales by Region (2017-2022) & (K Units)
Table 43. APAC Psoriasis Biologics Drugs Sales Market Share by Region (2017-2022)
Table 44. APAC Psoriasis Biologics Drugs Revenue by Region (2017-2022) & ($ Millions)
Table 45. APAC Psoriasis Biologics Drugs Revenue Market Share by Region (2017-2022)
Table 46. APAC Psoriasis Biologics Drugs Sales by Type (2017-2022) & (K Units)
Table 47. APAC Psoriasis Biologics Drugs Sales Market Share by Type (2017-2022)
Table 48. APAC Psoriasis Biologics Drugs Sales by Application (2017-2022) & (K Units)
Table 49. APAC Psoriasis Biologics Drugs Sales Market Share by Application (2017-2022)
Table 50. Europe Psoriasis Biologics Drugs Sales by Country (2017-2022) & (K Units)
Table 51. Europe Psoriasis Biologics Drugs Sales Market Share by Country (2017-2022)
Table 52. Europe Psoriasis Biologics Drugs Revenue by Country (2017-2022) & ($ Millions)
Table 53. Europe Psoriasis Biologics Drugs Revenue Market Share by Country (2017-2022)
Table 54. Europe Psoriasis Biologics Drugs Sales by Type (2017-2022) & (K Units)
Table 55. Europe Psoriasis Biologics Drugs Sales Market Share by Type (2017-2022)
Table 56. Europe Psoriasis Biologics Drugs Sales by Application (2017-2022) & (K Units)
Table 57. Europe Psoriasis Biologics Drugs Sales Market Share by Application (2017-2022)
Table 58. Middle East & Africa Psoriasis Biologics Drugs Sales by Country (2017-2022) & (K Units)
Table 59. Middle East & Africa Psoriasis Biologics Drugs Sales Market Share by Country (2017-2022)
Table 60. Middle East & Africa Psoriasis Biologics Drugs Revenue by Country (2017-2022) & ($ Millions)
Table 61. Middle East & Africa Psoriasis Biologics Drugs Revenue Market Share by Country (2017-2022)
Table 62. Middle East & Africa Psoriasis Biologics Drugs Sales by Type (2017-2022) & (K Units)
Table 63. Middle East & Africa Psoriasis Biologics Drugs Sales Market Share by Type (2017-2022)
Table 64. Middle East & Africa Psoriasis Biologics Drugs Sales by Application (2017-2022) & (K Units)
Table 65. Middle East & Africa Psoriasis Biologics Drugs Sales Market Share by Application (2017-2022)
Table 66. Key Market Drivers & Growth Opportunities of Psoriasis Biologics Drugs
Table 67. Key Market Challenges & Risks of Psoriasis Biologics Drugs
Table 68. Key Industry Trends of Psoriasis Biologics Drugs
Table 69. Psoriasis Biologics Drugs Raw Material
Table 70. Key Suppliers of Raw Materials
Table 71. Psoriasis Biologics Drugs Distributors List
Table 72. Psoriasis Biologics Drugs Customer List
Table 73. Global Psoriasis Biologics Drugs Sales Forecast by Region (2023-2028) & (K Units)
Table 74. Global Psoriasis Biologics Drugs Sales Market Forecast by Region
Table 75. Global Psoriasis Biologics Drugs Revenue Forecast by Region (2023-2028) & ($ millions)
Table 76. Global Psoriasis Biologics Drugs Revenue Market Share Forecast by Region (2023-2028)
Table 77. Americas Psoriasis Biologics Drugs Sales Forecast by Country (2023-2028) & (K Units)
Table 78. Americas Psoriasis Biologics Drugs Revenue Forecast by Country (2023-2028) & ($ millions)
Table 79. APAC Psoriasis Biologics Drugs Sales Forecast by Region (2023-2028) & (K Units)
Table 80. APAC Psoriasis Biologics Drugs Revenue Forecast by Region (2023-2028) & ($ millions)
Table 81. Europe Psoriasis Biologics Drugs Sales Forecast by Country (2023-2028) & (K Units)
Table 82. Europe Psoriasis Biologics Drugs Revenue Forecast by Country (2023-2028) & ($ millions)
Table 83. Middle East & Africa Psoriasis Biologics Drugs Sales Forecast by Country (2023-2028) & (K Units)
Table 84. Middle East & Africa Psoriasis Biologics Drugs Revenue Forecast by Country (2023-2028) & ($ millions)
Table 85. Global Psoriasis Biologics Drugs Sales Forecast by Type (2023-2028) & (K Units)
Table 86. Global Psoriasis Biologics Drugs Sales Market Share Forecast by Type (2023-2028)
Table 87. Global Psoriasis Biologics Drugs Revenue Forecast by Type (2023-2028) & ($ Millions)
Table 88. Global Psoriasis Biologics Drugs Revenue Market Share Forecast by Type (2023-2028)
Table 89. Global Psoriasis Biologics Drugs Sales Forecast by Application (2023-2028) & (K Units)
Table 90. Global Psoriasis Biologics Drugs Sales Market Share Forecast by Application (2023-2028)
Table 91. Global Psoriasis Biologics Drugs Revenue Forecast by Application (2023-2028) & ($ Millions)
Table 92. Global Psoriasis Biologics Drugs Revenue Market Share Forecast by Application (2023-2028)
Table 93. Amgen Basic Information, Psoriasis Biologics Drugs Manufacturing Base, Sales Area and Its Competitors
Table 94. Amgen Psoriasis Biologics Drugs Product Offered
Table 95. Amgen Psoriasis Biologics Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 96. Amgen Main Business
Table 97. Amgen Latest Developments
Table 98. UCB Basic Information, Psoriasis Biologics Drugs Manufacturing Base, Sales Area and Its Competitors
Table 99. UCB Psoriasis Biologics Drugs Product Offered
Table 100. UCB Psoriasis Biologics Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 101. UCB Main Business
Table 102. UCB Latest Developments
Table 103. Johnson & Johnson Basic Information, Psoriasis Biologics Drugs Manufacturing Base, Sales Area and Its Competitors
Table 104. Johnson & Johnson Psoriasis Biologics Drugs Product Offered
Table 105. Johnson & Johnson Psoriasis Biologics Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 106. Johnson & Johnson Main Business
Table 107. Johnson & Johnson Latest Developments
Table 108. Abbive Basic Information, Psoriasis Biologics Drugs Manufacturing Base, Sales Area and Its Competitors
Table 109. Abbive Psoriasis Biologics Drugs Product Offered
Table 110. Abbive Psoriasis Biologics Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 111. Abbive Main Business
Table 112. Abbive Latest Developments
Table 113. Innovent Basic Information, Psoriasis Biologics Drugs Manufacturing Base, Sales Area and Its Competitors
Table 114. Innovent Psoriasis Biologics Drugs Product Offered
Table 115. Innovent Psoriasis Biologics Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 116. Innovent Main Business
Table 117. Innovent Latest Developments
Table 118. Biocad Basic Information, Psoriasis Biologics Drugs Manufacturing Base, Sales Area and Its Competitors
Table 119. Biocad Psoriasis Biologics Drugs Product Offered
Table 120. Biocad Psoriasis Biologics Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 121. Biocad Main Business
Table 122. Biocad Latest Developments
Table 123. Novartis Basic Information, Psoriasis Biologics Drugs Manufacturing Base, Sales Area and Its Competitors
Table 124. Novartis Psoriasis Biologics Drugs Product Offered
Table 125. Novartis Psoriasis Biologics Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 126. Novartis Main Business
Table 127. Novartis Latest Developments
Table 128. Eli Lilly Basic Information, Psoriasis Biologics Drugs Manufacturing Base, Sales Area and Its Competitors
Table 129. Eli Lilly Psoriasis Biologics Drugs Product Offered
Table 130. Eli Lilly Psoriasis Biologics Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 131. Eli Lilly Main Business
Table 132. Eli Lilly Latest Developments
Table 133. Sun Pharmaceutical Basic Information, Psoriasis Biologics Drugs Manufacturing Base, Sales Area and Its Competitors
Table 134. Sun Pharmaceutical Psoriasis Biologics Drugs Product Offered
Table 135. Sun Pharmaceutical Psoriasis Biologics Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 136. Sun Pharmaceutical Main Business
Table 137. Sun Pharmaceutical Latest Developments
Table 1. Psoriasis Biologics Drugs Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)
Table 2. Psoriasis Biologics Drugs Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)
Table 3. Major Players of TNF-? Inhibitor
Table 4. Major Players of IL-12/23 Target Drug
Table 5. Major Players of IL-17 Target Drug
Table 6. Global Psoriasis Biologics Drugs Sales by Type (2017-2022) & (K Units)
Table 7. Global Psoriasis Biologics Drugs Sales Market Share by Type (2017-2022)
Table 8. Global Psoriasis Biologics Drugs Revenue by Type (2017-2022) & ($ million)
Table 9. Global Psoriasis Biologics Drugs Revenue Market Share by Type (2017-2022)
Table 10. Global Psoriasis Biologics Drugs Sale Price by Type (2017-2022) & (US$/Unit)
Table 11. Global Psoriasis Biologics Drugs Sales by Application (2017-2022) & (K Units)
Table 12. Global Psoriasis Biologics Drugs Sales Market Share by Application (2017-2022)
Table 13. Global Psoriasis Biologics Drugs Revenue by Application (2017-2022)
Table 14. Global Psoriasis Biologics Drugs Revenue Market Share by Application (2017-2022)
Table 15. Global Psoriasis Biologics Drugs Sale Price by Application (2017-2022) & (US$/Unit)
Table 16. Global Psoriasis Biologics Drugs Sales by Company (2020-2022) & (K Units)
Table 17. Global Psoriasis Biologics Drugs Sales Market Share by Company (2020-2022)
Table 18. Global Psoriasis Biologics Drugs Revenue by Company (2020-2022) ($ Millions)
Table 19. Global Psoriasis Biologics Drugs Revenue Market Share by Company (2020-2022)
Table 20. Global Psoriasis Biologics Drugs Sale Price by Company (2020-2022) & (US$/Unit)
Table 21. Key Manufacturers Psoriasis Biologics Drugs Producing Area Distribution and Sales Area
Table 22. Players Psoriasis Biologics Drugs Products Offered
Table 23. Psoriasis Biologics Drugs Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
Table 24. New Products and Potential Entrants
Table 25. Mergers & Acquisitions, Expansion
Table 26. Global Psoriasis Biologics Drugs Sales by Geographic Region (2017-2022) & (K Units)
Table 27. Global Psoriasis Biologics Drugs Sales Market Share Geographic Region (2017-2022)
Table 28. Global Psoriasis Biologics Drugs Revenue by Geographic Region (2017-2022) & ($ millions)
Table 29. Global Psoriasis Biologics Drugs Revenue Market Share by Geographic Region (2017-2022)
Table 30. Global Psoriasis Biologics Drugs Sales by Country/Region (2017-2022) & (K Units)
Table 31. Global Psoriasis Biologics Drugs Sales Market Share by Country/Region (2017-2022)
Table 32. Global Psoriasis Biologics Drugs Revenue by Country/Region (2017-2022) & ($ millions)
Table 33. Global Psoriasis Biologics Drugs Revenue Market Share by Country/Region (2017-2022)
Table 34. Americas Psoriasis Biologics Drugs Sales by Country (2017-2022) & (K Units)
Table 35. Americas Psoriasis Biologics Drugs Sales Market Share by Country (2017-2022)
Table 36. Americas Psoriasis Biologics Drugs Revenue by Country (2017-2022) & ($ Millions)
Table 37. Americas Psoriasis Biologics Drugs Revenue Market Share by Country (2017-2022)
Table 38. Americas Psoriasis Biologics Drugs Sales by Type (2017-2022) & (K Units)
Table 39. Americas Psoriasis Biologics Drugs Sales Market Share by Type (2017-2022)
Table 40. Americas Psoriasis Biologics Drugs Sales by Application (2017-2022) & (K Units)
Table 41. Americas Psoriasis Biologics Drugs Sales Market Share by Application (2017-2022)
Table 42. APAC Psoriasis Biologics Drugs Sales by Region (2017-2022) & (K Units)
Table 43. APAC Psoriasis Biologics Drugs Sales Market Share by Region (2017-2022)
Table 44. APAC Psoriasis Biologics Drugs Revenue by Region (2017-2022) & ($ Millions)
Table 45. APAC Psoriasis Biologics Drugs Revenue Market Share by Region (2017-2022)
Table 46. APAC Psoriasis Biologics Drugs Sales by Type (2017-2022) & (K Units)
Table 47. APAC Psoriasis Biologics Drugs Sales Market Share by Type (2017-2022)
Table 48. APAC Psoriasis Biologics Drugs Sales by Application (2017-2022) & (K Units)
Table 49. APAC Psoriasis Biologics Drugs Sales Market Share by Application (2017-2022)
Table 50. Europe Psoriasis Biologics Drugs Sales by Country (2017-2022) & (K Units)
Table 51. Europe Psoriasis Biologics Drugs Sales Market Share by Country (2017-2022)
Table 52. Europe Psoriasis Biologics Drugs Revenue by Country (2017-2022) & ($ Millions)
Table 53. Europe Psoriasis Biologics Drugs Revenue Market Share by Country (2017-2022)
Table 54. Europe Psoriasis Biologics Drugs Sales by Type (2017-2022) & (K Units)
Table 55. Europe Psoriasis Biologics Drugs Sales Market Share by Type (2017-2022)
Table 56. Europe Psoriasis Biologics Drugs Sales by Application (2017-2022) & (K Units)
Table 57. Europe Psoriasis Biologics Drugs Sales Market Share by Application (2017-2022)
Table 58. Middle East & Africa Psoriasis Biologics Drugs Sales by Country (2017-2022) & (K Units)
Table 59. Middle East & Africa Psoriasis Biologics Drugs Sales Market Share by Country (2017-2022)
Table 60. Middle East & Africa Psoriasis Biologics Drugs Revenue by Country (2017-2022) & ($ Millions)
Table 61. Middle East & Africa Psoriasis Biologics Drugs Revenue Market Share by Country (2017-2022)
Table 62. Middle East & Africa Psoriasis Biologics Drugs Sales by Type (2017-2022) & (K Units)
Table 63. Middle East & Africa Psoriasis Biologics Drugs Sales Market Share by Type (2017-2022)
Table 64. Middle East & Africa Psoriasis Biologics Drugs Sales by Application (2017-2022) & (K Units)
Table 65. Middle East & Africa Psoriasis Biologics Drugs Sales Market Share by Application (2017-2022)
Table 66. Key Market Drivers & Growth Opportunities of Psoriasis Biologics Drugs
Table 67. Key Market Challenges & Risks of Psoriasis Biologics Drugs
Table 68. Key Industry Trends of Psoriasis Biologics Drugs
Table 69. Psoriasis Biologics Drugs Raw Material
Table 70. Key Suppliers of Raw Materials
Table 71. Psoriasis Biologics Drugs Distributors List
Table 72. Psoriasis Biologics Drugs Customer List
Table 73. Global Psoriasis Biologics Drugs Sales Forecast by Region (2023-2028) & (K Units)
Table 74. Global Psoriasis Biologics Drugs Sales Market Forecast by Region
Table 75. Global Psoriasis Biologics Drugs Revenue Forecast by Region (2023-2028) & ($ millions)
Table 76. Global Psoriasis Biologics Drugs Revenue Market Share Forecast by Region (2023-2028)
Table 77. Americas Psoriasis Biologics Drugs Sales Forecast by Country (2023-2028) & (K Units)
Table 78. Americas Psoriasis Biologics Drugs Revenue Forecast by Country (2023-2028) & ($ millions)
Table 79. APAC Psoriasis Biologics Drugs Sales Forecast by Region (2023-2028) & (K Units)
Table 80. APAC Psoriasis Biologics Drugs Revenue Forecast by Region (2023-2028) & ($ millions)
Table 81. Europe Psoriasis Biologics Drugs Sales Forecast by Country (2023-2028) & (K Units)
Table 82. Europe Psoriasis Biologics Drugs Revenue Forecast by Country (2023-2028) & ($ millions)
Table 83. Middle East & Africa Psoriasis Biologics Drugs Sales Forecast by Country (2023-2028) & (K Units)
Table 84. Middle East & Africa Psoriasis Biologics Drugs Revenue Forecast by Country (2023-2028) & ($ millions)
Table 85. Global Psoriasis Biologics Drugs Sales Forecast by Type (2023-2028) & (K Units)
Table 86. Global Psoriasis Biologics Drugs Sales Market Share Forecast by Type (2023-2028)
Table 87. Global Psoriasis Biologics Drugs Revenue Forecast by Type (2023-2028) & ($ Millions)
Table 88. Global Psoriasis Biologics Drugs Revenue Market Share Forecast by Type (2023-2028)
Table 89. Global Psoriasis Biologics Drugs Sales Forecast by Application (2023-2028) & (K Units)
Table 90. Global Psoriasis Biologics Drugs Sales Market Share Forecast by Application (2023-2028)
Table 91. Global Psoriasis Biologics Drugs Revenue Forecast by Application (2023-2028) & ($ Millions)
Table 92. Global Psoriasis Biologics Drugs Revenue Market Share Forecast by Application (2023-2028)
Table 93. Amgen Basic Information, Psoriasis Biologics Drugs Manufacturing Base, Sales Area and Its Competitors
Table 94. Amgen Psoriasis Biologics Drugs Product Offered
Table 95. Amgen Psoriasis Biologics Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 96. Amgen Main Business
Table 97. Amgen Latest Developments
Table 98. UCB Basic Information, Psoriasis Biologics Drugs Manufacturing Base, Sales Area and Its Competitors
Table 99. UCB Psoriasis Biologics Drugs Product Offered
Table 100. UCB Psoriasis Biologics Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 101. UCB Main Business
Table 102. UCB Latest Developments
Table 103. Johnson & Johnson Basic Information, Psoriasis Biologics Drugs Manufacturing Base, Sales Area and Its Competitors
Table 104. Johnson & Johnson Psoriasis Biologics Drugs Product Offered
Table 105. Johnson & Johnson Psoriasis Biologics Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 106. Johnson & Johnson Main Business
Table 107. Johnson & Johnson Latest Developments
Table 108. Abbive Basic Information, Psoriasis Biologics Drugs Manufacturing Base, Sales Area and Its Competitors
Table 109. Abbive Psoriasis Biologics Drugs Product Offered
Table 110. Abbive Psoriasis Biologics Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 111. Abbive Main Business
Table 112. Abbive Latest Developments
Table 113. Innovent Basic Information, Psoriasis Biologics Drugs Manufacturing Base, Sales Area and Its Competitors
Table 114. Innovent Psoriasis Biologics Drugs Product Offered
Table 115. Innovent Psoriasis Biologics Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 116. Innovent Main Business
Table 117. Innovent Latest Developments
Table 118. Biocad Basic Information, Psoriasis Biologics Drugs Manufacturing Base, Sales Area and Its Competitors
Table 119. Biocad Psoriasis Biologics Drugs Product Offered
Table 120. Biocad Psoriasis Biologics Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 121. Biocad Main Business
Table 122. Biocad Latest Developments
Table 123. Novartis Basic Information, Psoriasis Biologics Drugs Manufacturing Base, Sales Area and Its Competitors
Table 124. Novartis Psoriasis Biologics Drugs Product Offered
Table 125. Novartis Psoriasis Biologics Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 126. Novartis Main Business
Table 127. Novartis Latest Developments
Table 128. Eli Lilly Basic Information, Psoriasis Biologics Drugs Manufacturing Base, Sales Area and Its Competitors
Table 129. Eli Lilly Psoriasis Biologics Drugs Product Offered
Table 130. Eli Lilly Psoriasis Biologics Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 131. Eli Lilly Main Business
Table 132. Eli Lilly Latest Developments
Table 133. Sun Pharmaceutical Basic Information, Psoriasis Biologics Drugs Manufacturing Base, Sales Area and Its Competitors
Table 134. Sun Pharmaceutical Psoriasis Biologics Drugs Product Offered
Table 135. Sun Pharmaceutical Psoriasis Biologics Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 136. Sun Pharmaceutical Main Business
Table 137. Sun Pharmaceutical Latest Developments
LIST OF FIGURES
Figure 1. Picture of Psoriasis Biologics Drugs
Figure 2. Psoriasis Biologics Drugs Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Psoriasis Biologics Drugs Sales Growth Rate 2017-2028 (K Units)
Figure 7. Global Psoriasis Biologics Drugs Revenue Growth Rate 2017-2028 ($ Millions)
Figure 8. Psoriasis Biologics Drugs Sales by Region (2021 & 2028) & ($ millions)
Figure 9. Product Picture of TNF-? Inhibitor
Figure 10. Product Picture of IL-12/23 Target Drug
Figure 11. Product Picture of IL-17 Target Drug
Figure 12. Global Psoriasis Biologics Drugs Sales Market Share by Type in 2021
Figure 13. Global Psoriasis Biologics Drugs Revenue Market Share by Type (2017-2022)
Figure 14. Psoriasis Biologics Drugs Consumed in Hospital Pharmacies
Figure 15. Global Psoriasis Biologics Drugs Market: Hospital Pharmacies (2017-2022) & (K Units)
Figure 16. Psoriasis Biologics Drugs Consumed in Retail Pharmacies
Figure 17. Global Psoriasis Biologics Drugs Market: Retail Pharmacies (2017-2022) & (K Units)
Figure 18. Psoriasis Biologics Drugs Consumed in Online Pharmacies
Figure 19. Global Psoriasis Biologics Drugs Market: Online Pharmacies (2017-2022) & (K Units)
Figure 20. Global Psoriasis Biologics Drugs Sales Market Share by Application (2017-2022)
Figure 21. Global Psoriasis Biologics Drugs Revenue Market Share by Application in 2021
Figure 22. Psoriasis Biologics Drugs Revenue Market by Company in 2021 ($ Million)
Figure 23. Global Psoriasis Biologics Drugs Revenue Market Share by Company in 2021
Figure 24. Global Psoriasis Biologics Drugs Sales Market Share by Geographic Region (2017-2022)
Figure 25. Global Psoriasis Biologics Drugs Revenue Market Share by Geographic Region in 2021
Figure 26. Global Psoriasis Biologics Drugs Sales Market Share by Region (2017-2022)
Figure 27. Global Psoriasis Biologics Drugs Revenue Market Share by Country/Region in 2021
Figure 28. Americas Psoriasis Biologics Drugs Sales 2017-2022 (K Units)
Figure 29. Americas Psoriasis Biologics Drugs Revenue 2017-2022 ($ Millions)
Figure 30. APAC Psoriasis Biologics Drugs Sales 2017-2022 (K Units)
Figure 31. APAC Psoriasis Biologics Drugs Revenue 2017-2022 ($ Millions)
Figure 32. Europe Psoriasis Biologics Drugs Sales 2017-2022 (K Units)
Figure 33. Europe Psoriasis Biologics Drugs Revenue 2017-2022 ($ Millions)
Figure 34. Middle East & Africa Psoriasis Biologics Drugs Sales 2017-2022 (K Units)
Figure 35. Middle East & Africa Psoriasis Biologics Drugs Revenue 2017-2022 ($ Millions)
Figure 36. Americas Psoriasis Biologics Drugs Sales Market Share by Country in 2021
Figure 37. Americas Psoriasis Biologics Drugs Revenue Market Share by Country in 2021
Figure 38. United States Psoriasis Biologics Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 39. Canada Psoriasis Biologics Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 40. Mexico Psoriasis Biologics Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 41. Brazil Psoriasis Biologics Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 42. APAC Psoriasis Biologics Drugs Sales Market Share by Region in 2021
Figure 43. APAC Psoriasis Biologics Drugs Revenue Market Share by Regions in 2021
Figure 44. China Psoriasis Biologics Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 45. Japan Psoriasis Biologics Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 46. South Korea Psoriasis Biologics Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 47. Southeast Asia Psoriasis Biologics Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 48. India Psoriasis Biologics Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 49. Australia Psoriasis Biologics Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 50. Europe Psoriasis Biologics Drugs Sales Market Share by Country in 2021
Figure 51. Europe Psoriasis Biologics Drugs Revenue Market Share by Country in 2021
Figure 52. Germany Psoriasis Biologics Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 53. France Psoriasis Biologics Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 54. UK Psoriasis Biologics Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 55. Italy Psoriasis Biologics Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 56. Russia Psoriasis Biologics Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 57. Middle East & Africa Psoriasis Biologics Drugs Sales Market Share by Country in 2021
Figure 58. Middle East & Africa Psoriasis Biologics Drugs Revenue Market Share by Country in 2021
Figure 59. Egypt Psoriasis Biologics Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 60. South Africa Psoriasis Biologics Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 61. Israel Psoriasis Biologics Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 62. Turkey Psoriasis Biologics Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 63. GCC Country Psoriasis Biologics Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 64. Manufacturing Cost Structure Analysis of Psoriasis Biologics Drugs in 2021
Figure 65. Manufacturing Process Analysis of Psoriasis Biologics Drugs
Figure 66. Industry Chain Structure of Psoriasis Biologics Drugs
Figure 67. Channels of Distribution
Figure 68. Distributors Profiles
Figure 1. Picture of Psoriasis Biologics Drugs
Figure 2. Psoriasis Biologics Drugs Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Psoriasis Biologics Drugs Sales Growth Rate 2017-2028 (K Units)
Figure 7. Global Psoriasis Biologics Drugs Revenue Growth Rate 2017-2028 ($ Millions)
Figure 8. Psoriasis Biologics Drugs Sales by Region (2021 & 2028) & ($ millions)
Figure 9. Product Picture of TNF-? Inhibitor
Figure 10. Product Picture of IL-12/23 Target Drug
Figure 11. Product Picture of IL-17 Target Drug
Figure 12. Global Psoriasis Biologics Drugs Sales Market Share by Type in 2021
Figure 13. Global Psoriasis Biologics Drugs Revenue Market Share by Type (2017-2022)
Figure 14. Psoriasis Biologics Drugs Consumed in Hospital Pharmacies
Figure 15. Global Psoriasis Biologics Drugs Market: Hospital Pharmacies (2017-2022) & (K Units)
Figure 16. Psoriasis Biologics Drugs Consumed in Retail Pharmacies
Figure 17. Global Psoriasis Biologics Drugs Market: Retail Pharmacies (2017-2022) & (K Units)
Figure 18. Psoriasis Biologics Drugs Consumed in Online Pharmacies
Figure 19. Global Psoriasis Biologics Drugs Market: Online Pharmacies (2017-2022) & (K Units)
Figure 20. Global Psoriasis Biologics Drugs Sales Market Share by Application (2017-2022)
Figure 21. Global Psoriasis Biologics Drugs Revenue Market Share by Application in 2021
Figure 22. Psoriasis Biologics Drugs Revenue Market by Company in 2021 ($ Million)
Figure 23. Global Psoriasis Biologics Drugs Revenue Market Share by Company in 2021
Figure 24. Global Psoriasis Biologics Drugs Sales Market Share by Geographic Region (2017-2022)
Figure 25. Global Psoriasis Biologics Drugs Revenue Market Share by Geographic Region in 2021
Figure 26. Global Psoriasis Biologics Drugs Sales Market Share by Region (2017-2022)
Figure 27. Global Psoriasis Biologics Drugs Revenue Market Share by Country/Region in 2021
Figure 28. Americas Psoriasis Biologics Drugs Sales 2017-2022 (K Units)
Figure 29. Americas Psoriasis Biologics Drugs Revenue 2017-2022 ($ Millions)
Figure 30. APAC Psoriasis Biologics Drugs Sales 2017-2022 (K Units)
Figure 31. APAC Psoriasis Biologics Drugs Revenue 2017-2022 ($ Millions)
Figure 32. Europe Psoriasis Biologics Drugs Sales 2017-2022 (K Units)
Figure 33. Europe Psoriasis Biologics Drugs Revenue 2017-2022 ($ Millions)
Figure 34. Middle East & Africa Psoriasis Biologics Drugs Sales 2017-2022 (K Units)
Figure 35. Middle East & Africa Psoriasis Biologics Drugs Revenue 2017-2022 ($ Millions)
Figure 36. Americas Psoriasis Biologics Drugs Sales Market Share by Country in 2021
Figure 37. Americas Psoriasis Biologics Drugs Revenue Market Share by Country in 2021
Figure 38. United States Psoriasis Biologics Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 39. Canada Psoriasis Biologics Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 40. Mexico Psoriasis Biologics Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 41. Brazil Psoriasis Biologics Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 42. APAC Psoriasis Biologics Drugs Sales Market Share by Region in 2021
Figure 43. APAC Psoriasis Biologics Drugs Revenue Market Share by Regions in 2021
Figure 44. China Psoriasis Biologics Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 45. Japan Psoriasis Biologics Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 46. South Korea Psoriasis Biologics Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 47. Southeast Asia Psoriasis Biologics Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 48. India Psoriasis Biologics Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 49. Australia Psoriasis Biologics Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 50. Europe Psoriasis Biologics Drugs Sales Market Share by Country in 2021
Figure 51. Europe Psoriasis Biologics Drugs Revenue Market Share by Country in 2021
Figure 52. Germany Psoriasis Biologics Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 53. France Psoriasis Biologics Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 54. UK Psoriasis Biologics Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 55. Italy Psoriasis Biologics Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 56. Russia Psoriasis Biologics Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 57. Middle East & Africa Psoriasis Biologics Drugs Sales Market Share by Country in 2021
Figure 58. Middle East & Africa Psoriasis Biologics Drugs Revenue Market Share by Country in 2021
Figure 59. Egypt Psoriasis Biologics Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 60. South Africa Psoriasis Biologics Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 61. Israel Psoriasis Biologics Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 62. Turkey Psoriasis Biologics Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 63. GCC Country Psoriasis Biologics Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 64. Manufacturing Cost Structure Analysis of Psoriasis Biologics Drugs in 2021
Figure 65. Manufacturing Process Analysis of Psoriasis Biologics Drugs
Figure 66. Industry Chain Structure of Psoriasis Biologics Drugs
Figure 67. Channels of Distribution
Figure 68. Distributors Profiles
